Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F18%3A10371069" target="_blank" >RIV/00064165:_____/18:10371069 - isvavai.cz</a>

Result on the web

<a href="https://doi.org/10.1016/S0140-6736(17)32137-2" target="_blank" >https://doi.org/10.1016/S0140-6736(17)32137-2</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/S0140-6736(17)32137-2" target="_blank" >10.1016/S0140-6736(17)32137-2</a>

Result language

angličtina

Original language name

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Original language description

We compared the anti-fracture efficacy of teriparatide with risedronate in patients with severe osteoporosis. Among post-menopausal women with severe osteoporosis, the risk of new vertebral and clinical fractures is significantly lower in patients receiving teriparatide than in those receiving risedronate.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30202 - Endocrinology and metabolism (including diabetes, hormones)

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

The Lancet

ISSN

0140-6736

e-ISSN

—

Volume of the periodical

391

Issue of the periodical within the volume

10117

Country of publishing house

GB - UNITED KINGDOM

Number of pages

11

Pages from-to

230-240

UT code for WoS article

000423867000025

EID of the result in the Scopus database

2-s2.0-85033433482